ArticleVaccine2022

COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes.

Leàn Rolfes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.